The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations
- PMID: 19217814
- DOI: 10.1016/j.ymgme.2008.12.018
The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations
Abstract
Investigation of seven patients from three families suspected of a fatty acid oxidation defect showed mean CPT-I enzyme activity of 5.9+/-4.9 percent of normal controls. The families, two Inuit, one First Nation, live in areas of Canada geographically very distant from each other. The CPT1 and CPT2 genes were fully sequenced in 5 of the patients. All were homozygous for the same P479L mutation in a highly conserved region of the CPT1 gene. Two patients from the first family were also homozygous for the CPT2 F352C polymorphism in the CPT2 gene. Genotyping the patients and their family members confirmed that all seven patients were homozygous for the P479L variant allele in the CPT1 gene, as were 27 of 32 family members. Three of the seven patients and two cousins had hypoketotic hypoglycemia attributable to CPT-Ia deficiency, but adults homozygous for the variant denied hypoglycemia. We screened 422 consecutive newborns from the region of one of the Inuit families for this variant; 294 were homozygous, 103 heterozygous, and only 25 homozygous normal; thus the frequency of this variant allele is 0.81. There was an infant death in one family and at least 10 more deaths in those infants (7 homozygous, 3 heterozygous) consecutively tested for the mutation at birth. Thus there is an astonishingly high frequency of CPT1 P479L variant and, judging from the enzyme analysis in the seven patients, also CPT-I deficiency in the areas of Canada inhabited by these families. Despite the deficiency of CPT-Ia which is the major rate-limiting enzyme for long chain fatty acid oxidation, clinical effects, with few exceptions, were slight or absent. One clue to explaining this paradox is that, judging from the fatty acid oxidation studies in whole blood and fibroblasts, the low residual activity of CPT-Ia is sufficient to allow a reasonable flux through the mitochondrial oxidation system. It is likely that the P479L variant is of ancient origin and presumably its preservation must have conveyed some advantage.
Similar articles
-
Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut.Mol Genet Metab. 2010 Oct-Nov;101(2-3):200-4. doi: 10.1016/j.ymgme.2010.07.013. Epub 2010 Jul 24. Mol Genet Metab. 2010. PMID: 20696606
-
Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I.J Lipid Res. 2009 Jun;50(6):1223-8. doi: 10.1194/jlr.P900001-JLR200. Epub 2009 Jan 29. J Lipid Res. 2009. PMID: 19181627 Free PMC article.
-
Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.PLoS One. 2015 Mar 17;10(3):e0119936. doi: 10.1371/journal.pone.0119936. eCollection 2015. PLoS One. 2015. PMID: 25781464 Free PMC article.
-
Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data.Genet Med. 2017 Aug;19(8):851-857. doi: 10.1038/gim.2016.202. Epub 2017 Jan 26. Genet Med. 2017. PMID: 28125087 Free PMC article. Review.
-
Carnitine palmitoyltransferase deficiencies.Mol Genet Metab. 1999 Dec;68(4):424-40. doi: 10.1006/mgme.1999.2938. Mol Genet Metab. 1999. PMID: 10607472 Review.
Cited by
-
Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity.J Mol Cell Cardiol. 2014 Oct;75:76-87. doi: 10.1016/j.yjmcc.2014.07.008. Epub 2014 Jul 24. J Mol Cell Cardiol. 2014. PMID: 25066696 Free PMC article.
-
A mild phenotype associated with KCNQ1 p.V205M mediated long QT syndrome in First Nations children of Northern British Columbia: effect of additional variants and considerations for management.Front Pediatr. 2024 May 31;12:1394105. doi: 10.3389/fped.2024.1394105. eCollection 2024. Front Pediatr. 2024. PMID: 38884101 Free PMC article.
-
Identifying adaptive alleles in the human genome: from selection mapping to functional validation.Hum Genet. 2021 Feb;140(2):241-276. doi: 10.1007/s00439-020-02206-7. Epub 2020 Jul 29. Hum Genet. 2021. PMID: 32728809 Review.
-
Hunter-gatherer genomics: evolutionary insights and ethical considerations.Curr Opin Genet Dev. 2016 Dec;41:1-7. doi: 10.1016/j.gde.2016.06.015. Epub 2016 Jul 9. Curr Opin Genet Dev. 2016. PMID: 27400119 Free PMC article. Review.
-
Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.J Inherit Metab Dis. 2013 Jul;36(4):645-58. doi: 10.1007/s10545-013-9611-5. Epub 2013 May 15. J Inherit Metab Dis. 2013. PMID: 23674167 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical